PJC
BIIB icon

Phillip James Consulting’s Biogen BIIB Stock Holding History

Phillip James Consulting’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$864 Hold
4
– – ﹤0.01% 287
2026
Q1 		$1K Buy
+4
New +$737 ﹤0.01% 259

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Phillip James Consulting's BIIB Position: Q2 2026 in Review

Phillip James Consulting held its Biogen (BIIB) position steady in Q2 2026 at 4 shares worth $864. The position accounts for ﹤0.01% of the portfolio, ranked #287.

Phillip James Consulting first reported a position in BIIB in Q1 2026 and has held it in 2 quarters since. The position peaked at $1K in Q1 2026. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Phillip James Consulting held 4 shares of Biogen worth $864 as of Q2 2026.
  • Phillip James Consulting left its Biogen share count unchanged in Q2 2026.
  • Biogen made up ﹤0.01% of Phillip James Consulting's portfolio in Q2 2026, its #287 holding.
  • Phillip James Consulting first reported a position in Biogen in Q1 2026 and has held it in 2 quarters since.
  • Phillip James Consulting's Biogen position peaked at $1K in Q1 2026.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Phillip James Consulting's 13F filing for Q2 2026, filed 28 Jul 2026.